EUDA Health Holdings Limited (EUDA) shares rose 28.31 percent, or $0.39, to $1.75 on Tuesday, after the company announced a major acceleration of its longevity and regenerative medicine strategy, including the launch of a comprehensive stem cell therapy platform and the establishment of its first clinic in Shenzhen, China.
Shares were trading at $1.75, up from a previous close of $1.36 on the Nasdaq. The stock opened at $1.39 and moved within a day's range of $1.39 to $2.19. Trading volume reached about 4.22 million shares, well above the average volume of roughly 97,700 shares.
EUDA Health Holdings has a 52-week trading range of $1.03 to $4.70.
For comments and feedback contact: editorial@rttnews.com
Business News
September 04, 2026 15:08 ET The job report and foreign trade data were the main economic news from the U.S. in the first week of September. Elsewhere in North America, the Canadian central bank announced its latest policy decision. Inflation data from Eurozone was the highlight in Europe. The latest interest rate decision by the Reserve Bank of New Zealand drew attention in Asia.